论文部分内容阅读
宫颈腺癌综合治疗后(手术和/或放疗后)卵巢功能降低甚至丧失,引起近期绝经症状及某些远期疾病,如高血压、冠心病、糖尿病及骨质疏松等,严重影响患者生活质量。绝经激素治疗能够有效缓解上述症状,显著提高生活质量,但其在宫颈腺癌患者的使用安全性问题上一直饱受争议。近年来随着相关临床试验的进展,该观点正在逐渐发生转变。
Cervical adenocarcinoma after treatment (surgery and / or radiotherapy) to reduce or even loss of ovarian function, causing recent menopausal symptoms and some long-term diseases such as hypertension, coronary heart disease, diabetes and osteoporosis, etc., seriously affect the quality of life of patients . Menopause hormone therapy can effectively alleviate the above symptoms, significantly improve the quality of life, but its safety in the use of cervical adenocarcinoma has been controversial. In recent years, with the progress of relevant clinical trials, this view is gradually changing.